Equipment and technology
Top centres are equipped with musculoskeletal ultrasound, advanced immunology labs and biologic infusion units; infrastructure is broadly comparable with international standards.

Explore hospitals in our directory that appear in Fudan University’s 2023 top-ten specialty rankings related to this health area. Each card identifies the specialty and position that connects the hospital to this category.
If you are researching immunology & rheumatology care in China or immunology & rheumatology treatment in China for yourself or a family member, the practical question is simple: how does care here compare with the best centres abroad? Below is a grounded, numbers-based comparison written for international patients.
China’s leading rheumatology and immunology department — Peking Union Medical College Hospital (PUMCH, ranked #1 in Fudan rheumatology for 10 consecutive years) — sits in the country’s first tier, with Peking University People’s Hospital and the PLA General Hospital also strong. As an international benchmark, the Johns Hopkins Division of Rheumatology (ranked #1 in the US by U.S. News) remains a global reference.
Top centres are equipped with musculoskeletal ultrasound, advanced immunology labs and biologic infusion units; infrastructure is broadly comparable with international standards.
China has among the world’s largest populations of rheumatoid arthritis and lupus patients, so diagnostic and treatment volumes at major centres are very large. Biologic and targeted therapies for RA, SLE and vasculitis are standard at the top centres. Relative gaps remain in the very newest targeted agents and in clinical-trial infrastructure versus Johns Hopkins and similar institutions.
Standard immunosuppressants and biologics (TNF/IL-6/JAK inhibitors) are widely available; the newest agents can reach China later than the US/EU — verify per drug.
China has a large rheumatology workforce; research output is growing. International leaders still set more original research and guidelines, but the gap is narrowing.
| Metric | China | Global benchmark | Read |
|---|---|---|---|
| RA / lupus burden | Among the world’s largest | US lower prevalence | Large scale, strong centres |
| Biologics & targeted therapies | Widely available at top centres | Johns Hopkins sets the standard | Comparable |
China has among the world’s largest rheumatoid arthritis and lupus populations (global disease databases).
Rheumatology and autoimmune care in China typically cost a fraction of US/EU prices — a core reason international patients consider immunology in China.
At most top centres, waits for consultation and biologic initiation are shorter than in many public systems; international patient departments usually offer expedited booking.
Major centres run international clinics with English-speaking coordinators and self-pay / commercial insurance handling — directly relevant if you are weighing best hospitals for rheumatoid arthritis in China.
Yes. Major rheumatology centres regularly treat international patients, and many have dedicated international departments. Suitability is decided case by case by the treating rheumatologist.
Yes. American patients commonly travel to China for planned autoimmune care, often for lower cost and shorter waits. Bring your records and allow time for translation and coordination.
The largest tertiary centres and their international departments provide English-speaking doctors and coordinators. For other settings, a medical interpreter or coordinator such as Wellward China is recommended.
Through a hospital international clinic, a local coordinator, or by contacting a service like Wellward China with your records and goals. Appointments at top centres can often be arranged faster than in many public systems.
A comparable course of care is typically a fraction of US prices in China, largely because of lower hospital and staffing costs. Exact figures vary by medication regimen and hospital — request a written quote per case.
US prices reflect hospital charges, specialist fees, insurance administration and high drug costs. That gap is exactly why some international patients explore autoimmune treatment in China as a pragmatic alternative.
For common, high-prevalence autoimmune needs — rheumatoid arthritis, lupus, vasculitis — China’s top centres are highly competitive on cost, access and scale. For the very newest targeted therapies, China can be an efficient, pragmatic option, ideally combined with an international second opinion.
Rheumatology and Allergy & Immunology are the primary specialty links. Dermatology is supplementary only when an immune or allergic concern presents in the skin. The Chinese labels below follow the names shown in the Fudan specialty rankings.
Primary association for rheumatic and many autoimmune conditions.
Primary association for allergic and immune-system concerns.
May be relevant to selected immune-mediated or allergic skin presentations.
Cards merge hospitals that appear in more than one relevant specialty list. Each badge keeps its specialty and rank visible; none of the positions is a cross-specialty overall ranking.
The relevant specialty depends on the patient’s records, symptoms and goals. Browse the hospital directory or contact us to discuss practical information and coordination options.
Share your question, relevant records and intended travel timing. We can explain possible coordination steps.
Talk to a Concierge →